INTRODUCTION: Although the recent literature contains plenty of studies concerning all aspects of infective endocarditis (IE), very few focus on severe IE requiring admission to the ICU. RESULTS: In 2004, we published a report on the clinical spectrum and prognostic factors in 228 consecutive critically ill patients with IE. Septic shock, neurological complications and immunocompromised state were independently associated with in-hospital mortality. Cardiac surgery during the acute phase of EI was associated with better survival. A lot of information has been accumulated during the past 10 years on management of IE. Although three sets of blood cultures allow the identification of about 90% of cases, culture-negative IE still remains a diagnostic challenge. Blood-polymerase chain reaction in valve tissue may yield a microbiologic diagnosis. New imaging techniques such as positron emission tomography computed tomography (PET-CT) have shown additive value in patients with an intracardiac device or valvular prosthesis. Systematic cerebral magnetic resonance imaging can lead to modification of therapeutic plans. The decision to operate and the timing of cardiac surgery should take into account the presence of congestive heart failure, neurological complications, renal failure and multiorgan dysfunction syndrome. In 2011 and 2013, we published the results of a multicentre prospective observational study of 198 ICU patients with left-sided IE and confirmed that cardiac surgery was associated with better outcome. The strongest independent predictor of post-operative mortality was the pre-operative multiorgan failure score. Neurological failure also represented a major determinant of mortality, regardless of the mechanism of neurological complication. CONCLUSION: In the present paper, we propose algorithms to optimize the medico-surgical approach.
INTRODUCTION: Although the recent literature contains plenty of studies concerning all aspects of infective endocarditis (IE), very few focus on severe IE requiring admission to the ICU. RESULTS: In 2004, we published a report on the clinical spectrum and prognostic factors in 228 consecutive critically ill patients with IE. Septic shock, neurological complications and immunocompromised state were independently associated with in-hospital mortality. Cardiac surgery during the acute phase of EI was associated with better survival. A lot of information has been accumulated during the past 10 years on management of IE. Although three sets of blood cultures allow the identification of about 90% of cases, culture-negative IE still remains a diagnostic challenge. Blood-polymerase chain reaction in valve tissue may yield a microbiologic diagnosis. New imaging techniques such as positron emission tomography computed tomography (PET-CT) have shown additive value in patients with an intracardiac device or valvular prosthesis. Systematic cerebral magnetic resonance imaging can lead to modification of therapeutic plans. The decision to operate and the timing of cardiac surgery should take into account the presence of congestive heart failure, neurological complications, renal failure and multiorgan dysfunction syndrome. In 2011 and 2013, we published the results of a multicentre prospective observational study of 198 ICU patients with left-sided IE and confirmed that cardiac surgery was associated with better outcome. The strongest independent predictor of post-operative mortality was the pre-operative multiorgan failure score. Neurological failure also represented a major determinant of mortality, regardless of the mechanism of neurological complication. CONCLUSION: In the present paper, we propose algorithms to optimize the medico-surgical approach.
Authors: A Lefort; L Chartier; B Sendid; M Wolff; J-L Mainardi; I Podglajen; M Desnos-Ollivier; A Fontanet; S Bretagne; O Lortholary Journal: Clin Microbiol Infect Date: 2012-02-13 Impact factor: 8.067
Authors: Olcay Aksoy; Daniel J Sexton; Andrew Wang; Paul A Pappas; Wissam Kourany; Vivian Chu; Vance G Fowler; Christopher W Woods; John J Engemann; G Ralph Corey; Tina Harding; Christopher H Cabell Journal: Clin Infect Dis Date: 2007-01-02 Impact factor: 9.079
Authors: Tahaniyat Lalani; Christopher H Cabell; Daniel K Benjamin; Ovidiu Lasca; Christoph Naber; Vance G Fowler; G Ralph Corey; Vivian H Chu; Michael Fenely; Orathai Pachirat; Ru-San Tan; Richard Watkin; Adina Ionac; Asuncion Moreno; Carlos A Mestres; José Casabé; Natalia Chipigina; Damon P Eisen; Denis Spelman; Francois Delahaye; Gail Peterson; Lars Olaison; Andrew Wang Journal: Circulation Date: 2010-02-16 Impact factor: 29.690
Authors: Bruno Barsic; Stuart Dickerman; Vladimir Krajinovic; Paul Pappas; Javier Altclas; Giampiero Carosi; José H Casabé; Vivian H Chu; Francois Delahaye; Jameela Edathodu; Claudio Querido Fortes; Lars Olaison; Ana Pangercic; Mukesh Patel; Igor Rudez; Syahidah Syed Tamin; Josip Vincelj; Arnold S Bayer; Andrew Wang Journal: Clin Infect Dis Date: 2012-10-16 Impact factor: 9.079
Authors: David R Murdoch; G Ralph Corey; Bruno Hoen; José M Miró; Vance G Fowler; Arnold S Bayer; Adolf W Karchmer; Lars Olaison; Paul A Pappas; Philippe Moreillon; Stephen T Chambers; Vivian H Chu; Vicenç Falcó; David J Holland; Philip Jones; John L Klein; Nigel J Raymond; Kerry M Read; Marie Francoise Tripodi; Riccardo Utili; Andrew Wang; Christopher W Woods; Christopher H Cabell Journal: Arch Intern Med Date: 2009-03-09
Authors: Jean-François Timsit; Anders Perner; Jan Bakker; Matteo Bassetti; Dominique Benoit; Maurizio Cecconi; J Randall Curtis; Gordon S Doig; Margaret Herridge; Samir Jaber; Michael Joannidis; Laurent Papazian; Mark J Peters; Pierre Singer; Martin Smith; Marcio Soares; Antoni Torres; Antoine Vieillard-Baron; Giuseppe Citerio; Elie Azoulay Journal: Intensive Care Med Date: 2015-03-26 Impact factor: 17.440